Wow you are a prolific poster of incorrect information.
Stop referring to Nyrada's previous clinical studies. They have not completed any. They are pre-clinical, ANIMAL studies.
And I'm glad you updated your understanding of AGNs pre-clinical work. Yes they have very good results in TBI. Stroke is their first target indication, but TBI, HIE, heart attack and alzheimers also on the cards.
The reason why NYRs old timelines matter is becasue it's the same management team making the same/similar promises. That's my explanation for NYR being valued so low by the market - people don't trust them to deliver.
But I will continue to hold, though not buying more at this stage.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)